Analyst picks & changes

By BC Staff | Jan 30, 1995 | 8:00 AM GMT

Genentech Inc.

Genzyme Corp.

Piper Jaffray analyst Barbara Hoffman said she is enthusiastic about three cystic fibrosis therapies — Genentech Inc.'s

Pulmozyme

DNase,

Read the full 223 word article

How to gain access

Continue reading with a
two-week free trial.